IRIS
ALBISINNI, SIMONE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.456
AS - Asia 2.834
EU - Europa 1.996
SA - Sud America 550
AF - Africa 58
OC - Oceania 5
Totale 8.899
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.380
SG - Singapore 1.364
IT - Italia 890
HK - Hong Kong 486
BR - Brasile 457
CN - Cina 383
RU - Federazione Russa 362
VN - Vietnam 212
IE - Irlanda 189
JP - Giappone 173
NL - Olanda 166
DE - Germania 98
GB - Regno Unito 90
IN - India 44
FR - Francia 42
AR - Argentina 36
CA - Canada 31
MX - Messico 30
AT - Austria 27
TR - Turchia 27
PL - Polonia 24
ZA - Sudafrica 24
FI - Finlandia 22
BD - Bangladesh 20
UA - Ucraina 20
IQ - Iraq 19
ID - Indonesia 18
IR - Iran 18
EC - Ecuador 17
ES - Italia 17
PK - Pakistan 12
SE - Svezia 11
CL - Cile 10
KE - Kenya 8
KR - Corea 8
MY - Malesia 8
VE - Venezuela 8
BE - Belgio 7
PY - Paraguay 7
TN - Tunisia 7
IL - Israele 6
PE - Perù 6
CZ - Repubblica Ceca 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
SA - Arabia Saudita 5
AU - Australia 4
PH - Filippine 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CO - Colombia 3
GR - Grecia 3
HN - Honduras 3
KZ - Kazakistan 3
MA - Marocco 3
OM - Oman 3
PA - Panama 3
PT - Portogallo 3
SC - Seychelles 3
UZ - Uzbekistan 3
AL - Albania 2
AO - Angola 2
BG - Bulgaria 2
BO - Bolivia 2
CH - Svizzera 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
GE - Georgia 2
LT - Lituania 2
LU - Lussemburgo 2
NO - Norvegia 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TZ - Tanzania 2
BB - Barbados 1
CY - Cipro 1
DK - Danimarca 1
GH - Ghana 1
HR - Croazia 1
HU - Ungheria 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 8.899
Salva come PNG Salva come JPEG
Città #
Singapore 704
San Jose 512
Hong Kong 480
Ashburn 259
Woodbridge 234
Wilmington 215
Houston 189
Dublin 187
Beijing 184
Center 176
Tokyo 167
New York 136
The Dalles 104
Santa Clara 101
Council Bluffs 96
St. George 85
Ho Chi Minh City 84
Los Angeles 83
Milan 77
Rome 74
Buffalo 68
Moscow 53
São Paulo 51
Redondo Beach 46
Hanoi 42
London 36
Chicago 35
Nuremberg 28
Seattle 23
Florence 22
North Bergen 22
Warsaw 20
Brooklyn 19
Genoa 18
Lauterbourg 18
Turin 18
Tehran 17
Zhengzhou 17
Mexico City 16
Salt Lake City 16
Mülheim 15
Atlanta 14
Dallas 14
Johannesburg 14
Rio de Janeiro 14
Denver 13
Frankfurt am Main 13
Chennai 12
Elk Grove Village 12
Lappeenranta 12
Amsterdam 11
Montreal 11
Orem 11
Shanghai 11
Verona 11
Boston 10
Catania 10
Fairfield 10
Pune 10
Washington 10
Bologna 9
Jacksonville 9
Pesaro 9
Poplar 9
Belo Horizonte 8
Biên Hòa 8
Boardman 8
Brescia 8
Da Nang 8
Istanbul 8
Naples 8
Phoenix 8
Ancona 7
Bari 7
Charlotte 7
Curitiba 7
Guarulhos 7
Haiphong 7
Juiz de Fora 7
Pescara 7
Salvador 7
Schiffdorf 7
Tampa 7
Toronto 7
Vienna 7
Bragança Paulista 6
Guayaquil 6
Miami 6
Modena 6
Munich 6
Nairobi 6
San Francisco 6
Albignasego 5
Albuquerque 5
Ankara 5
Baghdad 5
Brasília 5
Caltana 5
Chandler 5
Dearborn 5
Totale 5.243
Salva come PNG Salva come JPEG
Nome #
External validation of the Briganti nomogram predicting lymph node invasion in patients with intermediate and high-risk prostate cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies: A European multicenter study 695
Abdominal obesity as risk factor for prostate cancer diagnosis and high grade disease: A prospective multicenter Italian cohort study 497
THE RELATION BETWEEN OBESITY AND PROSTATE CANCER: THE ROLE OF ABDOMINAL OBESITY AND BODY FRAME 399
18F-JK-PSMA-7 PET/CT for staging intermediate- or high-risk prostate cancer patients before radical prostatectomy: a pilot study 204
Clinical experience with 18F-JK-PSMA-7 when using a digital PET/CT 164
New treatment strategies for benign prostatic hyperplasia in the frail elderly population: A systematic review 108
Antibodies targeting prostate-specific membrane antigen positive prostate cancer: from diagnostic imaging to theranostics 99
The grade of systemic inflammation, immune inhibition, and gut dysbiosis as prognostic factors for bladder cancer recurrence: a metabolomics approach 98
Accuracy of frozen section analysis of urethral and ureteral margins during radical cystectomy for bladder cancer: a systematic review and diagnostic Meta-Analysis 93
Prospective per‐target analysis of the added value of the PrecisionPoint Transperineal Access System in cognitive prostate biopsy of MRI targets 87
CAR-T cell therapy for solid tumors: are we still that far? A systematic review of literature 83
Metastasis-directed therapy and prostate-targeted therapy in oligometastatic prostate cancer: a systematic review 81
Oncological and safety profiles in patients undergoing simultaneous transurethral resection (TUR) of bladder tumour and TUR of the prostate 80
Sexual dysfunction due to pudendal neuralgia: A systematic review 78
Pathological features of Prostate Imaging Reporting and Data System (PI-RADS) 3 MRI lesions in biopsy and radical prostatectomy specimens 78
A systematic review of imaging-guided metastasis-directed therapy for oligorecurrent prostate cancer: revolution or devolution? 74
Accuracy of elastic fusion biopsy: Comparing prostate cancer detection between targeted and systematic biopsy 74
Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: results from a large European cohort at the times of COVID-19 pandemic 74
Salvage Radical Prostatectomy for Recurrent Prostate Cancer: Morbidity and Functional Outcomes from a Large Multicenter Series of Open versus Robotic Approaches 74
Analysis of predictors of early trifecta achievement after robot-assisted radical prostatectomy for trainers and expert surgeons: the learning curve never ends 73
A systematic review and meta-analysis to evaluate the diagnostic accuracy of PSMA PET/CT in the initial staging of prostate cancer 73
New medical treatments for lower urinary tract symptoms due to benign prostatic hyperplasia and future perspectives 70
Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004 - AURA trial) 70
Radical Nephroureterectomy Tetrafecta: A Proposal Reporting Surgical Strategy Quality at Surgery 69
Management of chronic testicular pain due to thoracolumbar junction syndrome: A pilot study|La prise en charge de la douleur testiculaire chronique due a un syndrome de charniere thoraco-lombaire : étude pilote 69
Antibody-Drug Conjugates in Prostate Cancer: Where Are we? 69
Incidence, risk factors and outcomes of urethral recurrence after radical cystectomy for bladder cancer: A systematic review and meta-analysis 65
Continuing acetylsalicylic acid during Robotic-Assisted Radical Cystectomy with intracorporeal urinary diversion does not increase hemorrhagic complications: results from a large multicentric cohort 64
Immune checkpoint inhibitors for BCG-resistant NMIBC: the dawn of a new era 64
Anterior vs. retzius-sparing robotic assisted radical prostatectomy: can the approach really make a difference? 64
Laparoscopic treatment of pudendal nerve and artery entrapment improves erectile dysfunction in healthy young males 64
Robot-assisted radical cystectomy: towards a future of sexual-sparing surgery? 63
Cost-analysis of robot-assisted radical cystectomy in Europe: a cross-country comparison 63
Prostate cancer, androgen deprivation, and risk of COVID-19 infection: A systematic review and meta-analysis|Cancer de Prostate, déprivation androgénique, et risques d'infection par la COVID-19: revue systématique et méta-analyse 63
Advances in urothelial bladder cancer immunotherapy, dawn of a new age of treatment 63
Clinical validation of the intermediate-risk non–muscle-invasive bladder cancer scoring system and substratification model proposed by the International Bladder Cancer Group: A multicenter Young Academic Urologists Urothelial Working Group collaboration 62
Restaging transurethral resection in ta high-grade nonmuscle invasive bladder cancer: A systematic review 61
External Validation of a Multiparametric Magnetic Resonance Imaging–based Nomogram for the Prediction of Extracapsular Extension and Seminal Vesicle Invasion in Prostate Cancer Patients Undergoing Radical Prostatectomy 60
A systematic review of contemporary management of oligometastatic prostate cancer: fighting a challenge or tilting at windmills? 59
Enhancing Recovery After Major Bladder Cancer Surgery: Comprehensive Review and Assessment of Application of the Enhanced Recovery After Surgery Guidelines 59
Biomarkers for Renal Cell Carcinoma Recurrence: State of the Art 59
Indications for and complications of pelvic lymph node dissection in prostate cancer: accuracy of available nomograms for the prediction of lymph node invasion 58
The train has already left the station: Analyzing the rise of PSMA PET/ CT as new standard for staging high risk prostate cancer 58
Transvaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) in Urogynecological Surgery: A Systematic Review 57
68Ga-PSMA PET/CT-based metastasis-directed radiotherapy for oligometastatic prostate cancer recurrence after radical prostatectomy 57
Clinical effect of computed guided pudendal nerve block for patients with premature ejaculation: a pilot study 57
New Technologies for Kidney Surgery Planning 3D, Impression, Augmented Reality 3D, Reconstruction: Current Realities and Expectations 57
Current application of the enhanced recovery after surgery protocol for patients undergoing radical cystectomy: lessons learned from European excellence centers 57
Impact of sex on outcomes after surgery for non-muscle-invasive and muscle-invasive bladder urothelial carcinoma: a systematic review and meta-analysis 57
Setting new standards: robot-assisted radical prostatectomy as a day case 57
Urinary function in female patients after traditional, organ-sparing and nerve-sparing radical cystectomy for bladder cancer: a systematic review and pooled analysis 56
Fecal microbiota transplantation for immunotherapy-resistant urological tumors: Is it time? An update of the recent literature 56
Surgical checklist adherence across urology expertise levels impacts transurethral resection of bladder tumour quality indicators 56
Are Italian urologists and nurses ready for electronic instructions for use? A nationwide survey 56
Magnetic Resonance Imaging-Targeted Biopsy and Pretherapeutic Prostate Cancer Risk Assessment: a Systematic Review: Biopsie ciblée par Imagerie par résonance magnétique et évaluation pré-thérapeutique du risque de cancer de la prostate : revue systématique 56
Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era: A multicenter retrospective study 56
Prognostic role of neutrophil-to-lymphocyte ratio (NLR) in urological tumors: an umbrella review of evidence from systematic reviews and meta-analyses 55
A systematic review and meta-analysis comparing the outcomes of open and robotic assisted radical cystectomy 55
Enhanced Recovery After Surgery for patients undergoing radical cystectomy: Surgeons' perspectives and recommendations ten years after its implementation 55
The impact of preoperative venous thromboembolism on patients undergoing TURBT: Perioperative outcomes and healthcare costs from US insurance claims data 55
Thromboprophylaxis during neoadjuvant chemotherapy for bladder cancer reduces thromboembolism and bleeding 54
A Territory-wide Study Investigating the Dose and Efficacy of Different Bacillus Calmette-Guérin Strains in Patients with Intermediate- and High-risk Non–muscle-invasive Bladder Cancer 54
Compared Efficacy of Adjuvant Intravesical BCG-TICE vs. BCG-RIVM for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC): A Propensity Score Matched Analysis 53
Reassessment of the efficacy of carboplatin for metastatic urothelial carcinoma in the Era of immunotherapy: a systematic review and meta-analysis 53
Adjuvant immunotherapy in patients with renal cell carcinoma and urothelial carcinoma: A systematic review and network meta‐analysis 53
Defining the Morbidity of Robot-Assisted Radical Cystectomy with Intracorporeal Urinary Diversion: Adoption of the Comprehensive Complication Index 53
Urinary microbiota and prostatic diseases: the key for the lock? A systematic review 53
A prospective clinical trial of HIFU hemiablation for clinically localized prostate cancer 52
Can the success with immunotherapy in metastatic urothelial bladder carcinoma be replicated in the neoadjuvant setting? 52
Accuracy of elastic fusion biopsy in daily practice: Results of a multicenter study of 2115 patients 51
Bladder cancer at the time of COVID-19 outbreak 51
Does antibiotic use explain the discrepancy of urolithiasis prevalence between countries? 51
To what extent should we trust statistics? 51
Systematic review of neoadjuvant therapy by immune checkpoint inhibitors before radical cystectomy: where do we stand? 50
Prebiopsy 68Ga-PSMA PET imaging: can we improve the current diagnostic pathway for prostate cancer? 50
Uncovering the role of urinary microbiota in urological tumors: a systematic review of literature 49
Cartography-based quality control of prostate cancer care: A necessary ground to targeted focal therapy 49
Prognostic value of PlGF upregulation in prostate cancer 49
Long-term experience with early single Mitomycin C instillations in patients with low-risk non-muscle-invasive bladder cancer: Prospective, single-centre randomised trial 49
Myths, Superstitions, and Popular Beliefs: Do They Still Impact Our Practice? 48
External validation of models for prediction of side-specific extracapsular extension in prostate cancer patients undergoing radical prostatectomy 48
Serum levels of sex hormone binding globulin (SHBG) are not predictive of prostate cancer diagnosis and aggressiveness: results from an Italian biopsy cohort 47
Stratifying patients with intermediate-risk prostate cancer: Validation of a new model based on MRI parameters and targeted biopsy and comparison with NCCN and AUA subclassifications 47
COVID-19 and the male susceptibility: the role of ACE2, TMPRSS2 and the androgen receptor|COVID-19 et la susceptibilité du sexe masculin: le rôle de l'ACE2, la TMPRSS2 et le récepteur aux androgènes 47
Greater percent-free testosterone is associated with high-grade prostate cancer in men undergoing prostate biopsy 45
Evidence-based medicine, the number ‘three’ and its multiples in urological clinical rules 45
Contemporary management of benign uretero-enteric strictures after cystectomy: a systematic review 45
Focal therapy for prostate cancer: Making the punishment fit the crime|Thérapie focale pour le cancer de la prostate : une peine correspondante au crime 45
Efficacy of Different Bacillus of Calmette-Guérin (BCG) Strains on Recurrence Rates among Intermediate/High-Risk Non-Muscle Invasive Bladder Cancers (NMIBCs): Single-Arm Study Systematic Review, Cumulative and Network Meta-Analysis 45
Unlocking the Potential of Adequate Bacillus Calmette-Guérin Immunotherapy in Very-high-risk Non–muscle-invasive Bladder Carcinoma: A Multicenter Analysis of Oncological Outcomes and Risk Dynamics 44
Long-term analysis of oncological outcomes after laparoscopic radical cystectomy in Europe: Results from a multicentre study by the European Association of Urology (EAU) section of Uro-technology 43
The impact of lymphovascular invasion in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma: An extensive updated systematic review and meta-analysis 43
COVID-19 and BCG: where’s the challenge? 43
Transrectal prostate biopsy: easy, effective and safe 43
Salvage Hemiablation High Intensity Focused Ultrasound for unilateral radio-recurrent prostate cancer|Hémiablation prostatique de sauvetage par des ultrasons focalisés à haute intensité pour des récidives unilatérales après radiothérapie prostatique 42
Postoperative Chemotherapy Bladder Instillation After Radical Nephroureterectomy: Results of a European Survey from the Young Academic Urologist Urothelial Cancer Group 42
Variation in Follow-Up after Radical Cystectomy for Bladder Cancer—An Inventory Roundtable and Literature Review 42
A Novel Nomogram to Identify Candidates for Focal Therapy Among Patients with Localized Prostate Cancer Diagnosed via Magnetic Resonance Imaging-Targeted and Systematic Biopsies: A European Multicenter Study 41
A multicentric study on accurate grading of prostate cancer with systematic and MRI/US fusion targeted biopsies: comparison with final histopathology after radical prostatectomy 41
Predictive factors associated with biochemical recurrence following radical prostatectomy for pathological T2 prostate cancer with negative surgical margins 41
Totale 7.541
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.508
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.508
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 0 0 0 0 4 1
2021/202218 0 3 1 2 0 2 1 0 0 2 1 6
2022/2023806 2 1 1 1 2 628 80 5 14 7 44 21
2023/2024518 14 20 31 16 45 195 60 24 32 21 20 40
2024/20252.993 38 372 192 145 132 214 402 361 446 283 218 190
2025/20264.328 417 319 559 258 417 118 489 649 590 502 10 0
Totale 9.384